The Oncology Insights Podcast - Dr. Yelena Janjigian: Immunotherapy in GI Cancer Care | Ep. 3

In this episode of The Oncology Insights Podcast, Dr. Yelena Janjigian, Chief of Gastrointestinal Oncology at Memorial Sloan Kettering Cancer Center, shares results from the global MATTERHORN study and what it means for early-stage gastroesophageal cancer treatment. She explains how immunotherapy is shifting the treatment landscape, the real-world challenges of biomarker access, and why surgical collaboration matters. Listen now on all major platforms!

What you’ll learn: 

• Immunotherapy in early-stage
• Global clinical trial design
• Tumor biomarker limitations
• Surgery trial complexities
• Future of GI oncology

Meet the guest:

Dr. Yelena Janjigian is a physician-scientist and Chief of the Gastrointestinal Oncology Service at Memorial Sloan Kettering Cancer Center. Her research focuses on the molecular characterization of gastroesophageal cancers, aiming to bring innovative therapies to patients worldwide. With over 140 publications, she is a global leader in GI oncology. 

Listen to her insights now on The Oncology Insights Podcast, featuring Dr. Yelena Janjigian.

Connect with our guest on Social Media: LinkedIn

Liked this one? Don’t stop now. Here’s what we think you’ll love!